Ventilator-Associated Pneumonia Clinical Trial
Official title:
Impact of CT Scan and Lung Ultrasonogrpahy in Early Diagnostic Accuracy for Ventilation Acquired Lower Respiratory Tract Infections in Intensive Care Units.
We aim to show that systematic ultrasonography performed in ventilated patients suspected of
ventilation-acquired pneumonia could improve the accuracy of diagnostic of pneumonia, and
helps defining the diagnostic of tracheobronchitis when lower respiratory tract infection is
considered.
Chest CT scan is often performed before or just after admission in ICU, and usually show
abnormalities that are revealed later on standard radiographs.
This last exam is traditionally considered as the gold standard to prove new pulmonary
infiltrates, but the correlation with parenchymal consolidation is pretty low, and lead to
over-diagnosing pneumonia, thus leading to a massive and maybe sometimes unconsidered
prescription of antibiotic therapy.
Lung ultrasonography conducted systematically within the 3 first days after suspcion of
pneumonia could help making the difference between real infection-linked lesions, and banal
abnormalities following the hydric inflation of intra-thoracic organs, for instance pulmonary
edema or pleural effusion.
An independent evaluation using lung ultrasound, and analysis of CT scan acquisition when
performed, compared with the physician in charge of the patient appreciation by suggesting
him to provide his own probability of pneumonia upon routine clinical and biological datas.
Diagnostic of VAP and tracheobronchitis is often difficult in UC under mechanical
ventilation, and usually occuring quite early after initial phase of hemodynamic instability,
and characterized by needs of massive fluids supports and drugs infusion. The goldstandard is
still standard chest X-ray, providing a picture of the whole abnormalities due to cardiac
failure, and cardiogenic pulmonary edema. The high rate of water in chest of the patients
under ventilation assistance and hemodynamic support is responsible of a misinterpretation of
the abnormalities visualized on the radiographs. It is often considered that Lung
ultrasonography is useful to appreciate the involvement of pleural effusion, explaning
etiologies of hypoxemia, where cardiac failure is excluded by the simultaneous
ultrasonographic evaluation. However, it is not well recognized that pulmonary parenchyma can
be explored through echography, and that it provides a lot of information about the amount of
liquid inside it, and the default of aeration. Thus, it can in real time help the physician
to guide the therapeutics and manage the ventilation better. Moreover, the suspicion of
infection, clinically and biologically leads to the early prescription of antibiotics, given
that the radiography is abnormal. Knowing that there is now parenchymal consolidation but
rather effusion or a certain degree of pulmonary edema could help avoiding treating falsely a
respiratory infection.
The same thoughts can be held concerning Chest CT Scan, an exam often realized at the early
stage of management in a critical situation. We can take for granted that when occurring in
the 48 first hours of resuscitation, this exam shows in a certain number of cases preexisting
abnormalities, that are revealed severla hours later by Chest radiograph, when the suspicion
of respiratory infection acquired under ventilation emerge. If we take into account that
these abnormalities seen on radiographs are just correlated to those that could be seen on
CT, but with a certain delay, and are not de novo, it could lead to an overestimating of
ventilation acquired pneumonia, because the criteria of a new radiographic infiltrate won't
be valid anymore. The diagnostic of tracheobronchitis could then be more appropriated in a
certain number of situations.
Our aim is to verify retrospectively by an adjudication committee, that this early CT Scan,
within the 2 first days after admission if patient is ventilated and/or suspicion of lower
respiratory tract infection, and a systematic lung ultrasonographic evaluation, provided by
an independent operator, could change our appreciation of the frequency of
ventilation-acquired pneumonia, comparing to the appreciation of th physician in charge of
the patients.
We are thus conducting a repeated evaluation, at day 0, day 3 and day 7 with ultrasonography,
in order to give a probability of pneumonia or tracheobronchitis by the echographist
operator, and suggesting the physician to give his own probability based on clinical and
biological routine datas. We then measure the rate of agreement between the two parts, to see
how far the systematic evaluation using pleural ultrasonography could help defining the
probability of infection, and validating the diagnostic of pneumonia. The impact should be to
improve the accuracy within the first days 2 or 3 days after suspicion, when repeated, if
possible by the same operator. One of the main benefit could be the reduction or better
reevaluation of antibiotic therapy, if diagnostic of pneumonia is rejected secondary,
eventually shorter course of treatment could be chosen, even if this point deserve to be
evaluated in further studies.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01406951 -
Diagnostic Value of sTREM-1 and PCT Level as Well as CPIS Score for Ventilator-Associated Pneumonia Among ICU Sepsis Patients
|
N/A | |
Completed |
NCT00893763 -
Strategies To Prevent Pneumonia 2 (SToPP2)
|
Phase 2 | |
Recruiting |
NCT03581370 -
Short Infusion Versus Prolonged Infusion of Ceftolozane-tazobactam Among Patients With Ventilator Associated-pneumonia
|
Phase 3 | |
Completed |
NCT02070757 -
Safety and Efficacy Study of Ceftolozane/Tazobactam to Treat Ventilated Nosocomial Pneumonia (MK-7625A-008)
|
Phase 3 | |
Completed |
NCT03348579 -
Hospital-acquired Pneumonia in Intensive Care Unit
|
||
Completed |
NCT04242706 -
VITAL - VAP Prevention by BIP (Bactiguard Infection Protection) ETT Evac in Belgian ICUs
|
Phase 4 | |
Recruiting |
NCT05589727 -
Application of Ventilator-Associated Events (VAE) in Ventilator-Associated Pneumonia (VAP) Notified in Brazil
|
||
Not yet recruiting |
NCT06168734 -
Cefepime-taniborbactam vs Meropenem in Adults With VABP or Ventilated HABP
|
Phase 3 | |
Completed |
NCT02515448 -
A Pharmacokinetic-pharmacodynamic Dose Comparison Study of 8 mg/kg of Inhaled or Parenteral Gentamicin in 12 Mechanically Ventilated Critically Ill Patients Treated for Ventilator-associated Pneumonia
|
Phase 1 | |
Completed |
NCT01972425 -
Biomarker-based Exclusion of VAP for Improved Antibiotic Stewardship
|
N/A | |
Completed |
NCT02838160 -
Effectiveness of Different Educational Strategies on the KAP, Psychological and Clinical Outcomes
|
N/A | |
Completed |
NCT01467648 -
The Pharmacodynamics of Doripenem Between 4-hour and 1-hour Infusion in Patients With Ventilator-associated Pneumonia
|
Phase 4 | |
Completed |
NCT00364299 -
Prevention of Ventilator-Associated Pneumonia by Automatic Control of the Tracheal Tube Cuff Pressure
|
N/A | |
Completed |
NCT02515617 -
Medico-economic Study of the Subglottic Secretions Drainage in Prevention of Ventilator-associated Pneumonia (DEMETER)
|
N/A | |
Completed |
NCT02583308 -
Impact of the Subglottic Secretions Drainage on the Tracheal Secretions Colonisation
|
N/A | |
Completed |
NCT02585180 -
Subglottic Secretions Surveillance to Predict Bacterial Pathogens Involved in Ventilator-associated Pneumonia
|
N/A | |
Recruiting |
NCT01546974 -
Ventilator-associated Pneumonia (VAP) and Humidification System
|
Phase 4 | |
Completed |
NCT02060045 -
Prevention Ventilator Associated Pneumonia
|
N/A | |
Terminated |
NCT00543608 -
Clinical Efficacy of Intravenous Iclaprim Versus Vancomycin in the Treatment of Hospital-Acquired, Ventilator-Associated, or Health-Care-Associated Pneumonia
|
Phase 2 | |
Completed |
NCT02116699 -
Oropharyngeal Administration of Mother's Colostrum for Premature Infants (NS-72393-360)
|
N/A |